These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Physiologic factors in selecting human volunteers for drug studies. Azarnoff DL Clin Pharmacol Ther; 1972; 13(5):796-802. PubMed ID: 5054324 [No Abstract] [Full Text] [Related]
4. Introducing a new drug into clinical practice. Abrams WB Anesthesiology; 1971 Aug; 35(2):176-92. PubMed ID: 4998617 [No Abstract] [Full Text] [Related]
5. Generic equivalence and non-equivalence of drugs. Smith RN Lancet; 1972 Sep; 2(7776):528-30. PubMed ID: 4115582 [No Abstract] [Full Text] [Related]
6. Choice of subjects for in vivo studies in generic equivalency. Carr EA Ann Clin Res; 1974; 6(0):suppl 11:57-66. PubMed ID: 4855466 [No Abstract] [Full Text] [Related]
7. A scientific rationale for choosing patients rather than normal subjects for Phase I studies. Oates JA Clin Pharmacol Ther; 1972; 13(5):809-11. PubMed ID: 5054325 [No Abstract] [Full Text] [Related]
8. Bioavailability and pharmacokinetic analysis of drug responding systems. Smolen VF Annu Rev Pharmacol Toxicol; 1978; 18():495-522. PubMed ID: 348066 [No Abstract] [Full Text] [Related]
9. Bioavailability of drugs (second of two parts). Koch-Weser J N Engl J Med; 1974 Sep; 291(10):503-6. PubMed ID: 4604153 [No Abstract] [Full Text] [Related]
10. The conduct of initial drug studies in man. Dollery CT; Davies DS Br Med Bull; 1970 Sep; 26(3):233-6. PubMed ID: 4922458 [No Abstract] [Full Text] [Related]
11. [ANIMAL AND HUMAN EXPERIMENTATION WITH NEW DRUGS]. MARCONI M; DOMINICI A Clin Ter; 1964 Jun; 29():562-81. PubMed ID: 14184056 [No Abstract] [Full Text] [Related]